CoChat

The need to show minimum clinically important differences in Alzheimer's disease trials

Open access
Liu, Kathy Y, Schneider, Lon S, Howard, Robert · 2021 · The Lancet Psychiatry

The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.

Abstract

Deciding on the smallest change in an outcome that constitutes a clinically meaningful treatment effect (ie, the minimum clinically important difference [MCID]) is fundamental to interpreting clinical trial outcomes, making clinical decisions, and designing studies with sufficient statistical power to detect any such effect. There is no consensus on MCIDs for outcomes in Alzheimer's disease trials, but the US Food and Drug Administration's consideration of aducanumab clinical trials data has exposed the uncertainty of the clinical meaning of statistically significant but small improvements. Although MCIDs for outcomes, including Clinical Dementia Rating-Sum of Boxes and Mini-Mental State Examination in Alzheimer's disease have been reported, the Food and Drug Administration's guidelines, drafted in 1989 to facilitate regulatory approval of substantially effective antidementia drugs, do not specify quantified minimum differences. Although it is important that regulatory requirements encourage drug development and approval, without MCIDs, sponsors are motivated to power trials to detect statistical significance for only small and potentially inconsequential effects on clinical outcomes. MCIDs benefit patients, family members, caregivers, and health-care systems and should be incorporated into clinical trials and drug development guidance for Alzheimer's disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2215-0366(21)00197-8

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 131

Metadata

Authors
Liu, K. Y., Schneider, L. S., & Howard, R.
Affiliations
  • University College London (GB)
  • University of Southern California (US)
Corresponding author
Liu, Kathy Y
Venue
The Lancet Psychiatry
Publisher
Elsevier BV
Published
2021-11
Volume
8
Issue
11
Pages
1013-1016
ISSN
2215-0366 (ISSN-L)
OpenAlex
W3164682569
Cited by
113
References
30
Citations by year
2026: 6 · 2025: 22 · 2024: 23 · 2023: 34 · 2022: 21 · 2021: 7
FWCI
15.79
Type
journal article
Language
en
Open access
Locations
  • The Lancet Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • Biogen
  • Idaho Beef Council
  • Medical Research Council (MR/S021418/1)
  • Novartis
Topics
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
minimal clinically important difference, Alzheimer's disease, clinical trial results, aducanumab, FDA guidance, Clinical Dementia Rating, Mini-Mental State Examination, statistical power, anti-dementia drugs, drug development
MeSH terms
Clinical Decision-Making, Minimal Clinically Important Difference, Mental Status and Dementia Tests, Drug Development, Alzheimer Disease, Clinical Trials as Topic, Delivery of Health Care, Family, Humans, United States, United States Food and Drug Administration, Caregivers, Outcome Assessment, Health Care, Guidelines as Topic, Antibodies, Monoclonal, Humanized

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The need to show minimum clinically important differences in Alzheimer's disease trials. https://app.cochat.ai/papers/10.1016/s2215-0366(21)00197-8
The paper
Liu, K. Y., Schneider, L. S., & Howard, R. (2021). The need to show minimum clinically important differences in Alzheimer's disease trials. The Lancet Psychiatry. https://doi.org/10.1016/s2215-0366(21)00197-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.